Abstract
Sir, Primary antiphospholipid antibody syndrome (PAPS) is characterized by recurrent venous and arterial thrombosis, or both, or repeated fetal loss, associated with the presence of anticardiolipin (acL) or anti-β2 glycoprotein 1 (anti-β2 GP1) antibody or lupus anticoagulant (LAC) on two samples at least 8 weeks apart, in the absence of other connective-tissue disorders.1 Systemic manifestations are well recognized complications of PAPS. Renal involvement is not an uncommon complication of the disease, occurring in as many as 2.7–30% of patients.2,,3 In PAPS patients, renal impairment may indeed lead to: renal artery stenosis and/or malignant hypertension, renal infarction, renal vein thrombosis, thrombotic microangiopathy, increased allograft vascular thrombosis and reduced survival of renal allografts and non-thrombotic conditions like glomerulonephritis.2,,3 Urologic impairment has not been described in PAPS patients; only Fernandez-Rosado et al .4 have, in fact, reported the case of a patient with neurogenic bladder related to spinal cord thrombosis in a patient …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
